Literature DB >> 15509619

Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.

C Buhmann1, A Gorsler, T Bäumer, U Hidding, C Demiralay, K Hinkelmann, C Weiller, H R Siebner, A Münchau.   

Abstract

The dorsal premotor cortex (PMd) is abnormally active in patients with idiopathic Parkinson's disease. This has been interpreted as a functional correlate of adaptive plasticity within the motor system to compensate for deficient activation of striato-mesial-frontal projections in these patients. Whether abnormal PMd activity influences excitability in the primary motor cortex (M1) in untreated Parkinson's disease patients and how this premotor-motor interaction might be altered by l-dopa is unclear. To this end, we studied the effects of 1 Hz premotor repetitive transcranial magnetic stimulation (rTMS) on M1 excitability in 10 previously untreated non-tremulous Parkinson's disease patients before (day 1) and after (day 8) their first ever l-dopa treatment and compared the results with those of a group of nine age- and sex-matched healthy controls. In each rTMS session, 1200 pulses of 1 Hz rTMS were applied at an intensity of 80% active motor threshold (AMT) to the PMd contralateral to the clinically more affected side in Parkinson's disease patients and to the left PMd in healthy controls. Intracortical paired pulse excitability of ipsilateral M1 was probed using a TMS paired pulse paradigm where subthreshold conditioning pulses (80% of AMT) were given 2-15 ms prior to a suprathreshold test pulse. In Parkinson's disease patients, abnormal baseline intracortical excitability at an interstimulus interval (ISI) of 5 ms was normalized by premotor rTMS. In contrast, rTMS led to an increased excitability at an ISI of 5 ms in healthy controls. Premotor rTMS effects lasted longer (for at least a week) in patients. These results show that the modifiability of premotor-motor connections is abnormal in untreated Parkinson's disease. A single dose of l-dopa reversed, i.e. normalized, the direction of excitability changes in M1 following premotor rTMS in Parkinson's disease patients, suggesting that dopamine depletion directly or indirectly influences premotor-motor interactions in Parkinson's disease. The rTMS conditioning approach described here provides a promising tool to delineate further the excitability changes in frontal motor areas in response to progressive degeneration of nigrostriatal dopaminergic neurons and also to chronic l-dopa treatment in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509619     DOI: 10.1093/brain/awh321

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  28 in total

Review 1.  Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis.

Authors:  Aparna Wagle Shukla; Jonathan J Shuster; Jae Woo Chung; David E Vaillancourt; Carolynn Patten; Jill Ostrem; Michael S Okun
Journal:  PM R       Date:  2015-08-24       Impact factor: 2.298

2.  Controlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of Parkinson disease.

Authors:  David H Benninger; Kazumi Iseki; Sarah Kranick; David A Luckenbaugh; Elise Houdayer; Mark Hallett
Journal:  Neurorehabil Neural Repair       Date:  2012-05-15       Impact factor: 3.919

3.  Transcranial direct current stimulation for the treatment of Parkinson's disease.

Authors:  David H Benninger; Mikhail Lomarev; Grisel Lopez; Eric M Wassermann; Xiaobai Li; Elaine Considine; Mark Hallett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10       Impact factor: 10.154

4.  The supplementary motor area contributes to the timing of the anticipatory postural adjustment during step initiation in participants with and without Parkinson's disease.

Authors:  J V Jacobs; J S Lou; J A Kraakevik; F B Horak
Journal:  Neuroscience       Date:  2009-08-07       Impact factor: 3.590

Review 5.  Treatment and physiology in Parkinson's disease and dystonia: using transcranial magnetic stimulation to uncover the mechanisms of action.

Authors:  Aparna Wagle Shukla; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 6.  The role of neuroplasticity in dopaminergic therapy for Parkinson disease.

Authors:  Xiaoxi Zhuang; Pietro Mazzoni; Un Jung Kang
Journal:  Nat Rev Neurol       Date:  2013-04-16       Impact factor: 42.937

7.  Reduction of spasticity with repetitive transcranial magnetic stimulation in patients with spinal cord injury.

Authors:  Hatice Kumru; Narda Murillo; Joan Vidal Samso; Josep Valls-Sole; Dylan Edwards; Raul Pelayo; Antoni Valero-Cabre; Josep Maria Tormos; Alvaro Pascual-Leone
Journal:  Neurorehabil Neural Repair       Date:  2010-01-06       Impact factor: 3.919

8.  Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects.

Authors:  Brigida Fierro; Filippo Brighina; Marco D'Amelio; Ornella Daniele; Innocenzo Lupo; Paolo Ragonese; Antonio Palermo; Giovanni Savettieri
Journal:  Exp Brain Res       Date:  2007-09-08       Impact factor: 1.972

9.  Transcranial magnetic stimulation and connectivity mapping: tools for studying the neural bases of brain disorders.

Authors:  M Hampson; R E Hoffman
Journal:  Front Syst Neurosci       Date:  2010-08-12

Review 10.  Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.

Authors:  Matthew Vonloh; Robert Chen; Benzi Kluger
Journal:  Parkinsonism Relat Disord       Date:  2013-03-07       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.